ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 388

Pain, Fatigue and the Psychological Impact on Health-Related Quality of Life in Childhood-Onset Lupus

Jordan T. Jones1, Natoshia Cunningham2, Catherine Donnelly3, Susmita Kashikar-Zuck4 and Hermine I. Brunner5, 1Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Behavioral Medicine & Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Internal Medicine, University of Cincinnati, Cincinnati, OH, 4Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Pediatric Rheumatology Collaborative Study Group, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Fatigue, pain, Pediatric rheumatology, Quality of life and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects Poster I: Lupus, Scleroderma, JDMS

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Childhood-onset lupus (cSLE) is a chronic autoimmune disease that has negative impact on health-related quality of life (HRQoL), especially when increased disease activity and damage exist, however, even with well controlled disease, HRQoL with cSLE remains lower compared to healthy populations.  Chronic disease and related symptoms (pain, fatigue and poor sleep) as well as psychological factors (depression, anxiety and difficulty coping) can impair participation in developmentally appropriate activities. However, the impact of these potentially modifiable factors in relation to HRQoL in youth with cSLE is unknown.  Objectives of this study were to evaluate pain, fatigue and psychological functioning of cSLE patients and examine how these factors impact HRQoL.

 Methods: As part of an ongoing study,  cSLE patients (n= 65; 8 – 20 years) followed at Cincinnati Children’s Hospital, were asked to complete measures of pain (Pain visual analog scale), fatigue (PedsQL Multidimensional Fatigue Scale), depression (Children’s Depression Inventory I), anxiety (Screen for Child Anxiety Related Disorders), pain coping (Pain Coping questionnaire, Pain Catastrophizing scale), sleep (Adolescent Sleep Wake Scale), and HRQoL (PedsQL Generic Core scale and Rheumatology Module, Functional Disability Inventory).  Measures of disease activity (Systemic Lupus Erythematosus Disease Activity Index, and physician completed visual analog scale of cSLE disease activity [0-10; 0=inactive]) were also obtained.

Results: Subjects were 83% female with mean age of 16.1 years (SD 2.6) and mean SLEDAI score of 5.6 (SD 5.6). Fatigue was present in 63% of the patients; clinically relevant pain (Pain-VAS > 3), anxiety (SCARED ≥ 25) and depressive symptoms (CDI-I > 12) were observed in 38%, 38% and 31% of the patients, respectively; 60% had moderate catastrophizing (PCS ≥ 15). On average, the PedsQL-GC/RM for cSLE were lower than those observed in healthy populations (Table 1). Reduced PedsQL-GC/RM scores were highly correlated with greater levels of fatigue, anxiety, and depressive symptoms (Pearson r > 0.65), but had weak correlation with disease activity (Pearson r < 0.25). Regression analysis demonstrated HRQoL was most impacted by fatigue, and pain when evaluating all factors concurrently (p <0.001; Table 2).

Conclusion: cSLE is associated with decreased HRQoL, psychological aspects of health are prevalent and markedly contribute to low HRQoL. Fatigue, pain, and anxiety symptoms are present in a large subgroup of patients and need to be addressed to achieve optimal health outcomes.

 

Table 1. Health-related quality of life (HRQoL) and modifiable factors

Measures

Normative population

mean (SD)

cSLE

mean (SD)

Frequency, n (%) above cutoff value†

p-value

HRQoL Variables

PedsQL  Generic Core Scale

83.9 (12.5)

71.3 (18.4)

 

0.001

PedsQL  Rheumatology Module

84.4 (18.0)

73.8 (18.5)

 

0.001

Functional Disability Index (FDI)

 

6.9 (7.7)

 

 

       FDI > 12

 

 

11 (17%)

 

Modifiable Factors

Fatigue

80.5 (13.3)

57.5 (21.4)

 

0.001

Anxiety (SCARED)

 

22.3 (17.4)

 

 

       SCARED ≥ 25

 

 

25 (38%)

 

Mood (CDI-I)

 

9.8 (8.4)

 

 

       CDI-I > 12

 

 

20 (31%)

 

Pain (Pain-VAS)

 

2.8 (2.6)

 

 

       Pain-VAS > 3

 

 

25 (38%)

 

Pain Catastrophizing (PCS)

 

18.5 (11.6)

 

 

       PCS ≥ 15

 

 

39 (60%)

 

Pain Coping

 

2.6 (0.6)

*

 

Sleep

 

4.2 (0.5)

**

 

† Denotes cutoff values for clinically important symptoms for each variable where applicable

* Denotes no established normative or cutoff value; range 1-5, higher values = worse coping

** Denotes no established normative or cutoff value; range 1-6, higher values = better sleep

 

Table 2. Hierarchical regression analyses predicting HRQoL (PedsQL-GC & PedsQL-RM)

Predictor

Variable

Predicting PedsQL-GC

Predicting PedsQL-RM

β*

p-value

R2**

R2 change

β*

p-value

R2**

R2 change

Step 1

 

 

0.30

0.30

 

 

0.33

0.33

Pain

-0.55

<0.001

 

 

-0.57

<0.001

 

 

Step 2

 

 

0.71

0.41

 

 

0.55

0.22

Fatigue

0.70

<0.001

 

 

0.52

<0.001

 

 

Step 3

 

 

0.76

0.05

 

 

0.67

0.12

Anxiety

-0.14

0.13

 

 

-0.36

0.002

 

 

Mood

-0.21

0.06

 

 

-0.14

0.28

 

 

Coping

0.06

0.42

 

 

-0.06

0.50

 

 

Catastrophizing

-0.00

0.97

 

 

-0.04

0.72

 

 

* Represents the standardized coefficients

** Coefficient of multiple determination (how much model variance is predicted by each step, and the change with each additional step added to the model)


Disclosure: J. T. Jones, None; N. Cunningham, None; C. Donnelly, None; S. Kashikar-Zuck, None; H. I. Brunner, None.

To cite this abstract in AMA style:

Jones JT, Cunningham N, Donnelly C, Kashikar-Zuck S, Brunner HI. Pain, Fatigue and the Psychological Impact on Health-Related Quality of Life in Childhood-Onset Lupus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/pain-fatigue-and-the-psychological-impact-on-health-related-quality-of-life-in-childhood-onset-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pain-fatigue-and-the-psychological-impact-on-health-related-quality-of-life-in-childhood-onset-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology